Related Experiment Video
Updated: Jan 17, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
When in doubt, pig it out: a versatile translational platform to study CKD, HFpEF, and CKM syndrome
Alfonso Eirin1,2, Alejandro R Chade3,4,5
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States.
Insights
New swine models accurately mimic human chronic kidney disease (CKD), heart failure with preserved ejection fraction (HFpEF), and cardiovascular-kidney-metabolic (CKM) syndrome. These models aid in understanding disease mechanisms and developing novel therapeutic interventions.
Area of Science:
- Cardiovascular Science
- Nephrology
- Metabolic Disease Research
Background:
- Chronic kidney disease (CKD), heart failure with preserved ejection fraction (HFpEF), and cardiovascular-kidney-metabolic (CKM) syndrome pose significant health challenges with high morbidity and mortality.
- The complex pathophysiology of these conditions hinders effective prevention and treatment strategies.
- Large animal models are crucial for elucidating cardio-renal pathophysiology and advancing therapeutic discovery.
Purpose of the Study:
- To introduce and characterize novel swine models for CKD, HFpEF, and CKM syndrome.
- To investigate the impact of biological variables like sex and age on these cardio-renal-metabolic conditions.
- To identify key pathogenetic mechanisms and potential therapeutic targets.
Main Methods:
- Development and characterization of specialized swine models.
- Utilizing these models to study the impact of biological variables (sex, age) on disease progression.
- Analyzing data to reveal underlying pathophysiological mechanisms.
Main Results:
- Swine models closely recapitulate human CKD, HFpEF, and CKM syndrome.
- These models facilitate the study of disease mechanisms and the influence of sex and age.
- Key pathogenetic mechanisms and potential therapeutic targets were identified.
Conclusions:
- Novel swine models provide a powerful platform for studying cardio-renal-metabolic diseases.
- These models are instrumental in understanding disease pathogenesis and exploring new therapeutic avenues.
- Future research using these models will focus on developing innovative treatments for CKD, HFpEF, and CKM syndrome.
Abstract:
Chronic kidney disease (CKD), heart failure with preserved ejection fraction (HFpEF), and the recently defined cardiovascular-kidney-metabolic (CKM) syndrome are important challenges for the health care system, associated with a staggering increase in morbidity and mortality rates. Unfortunately, the complex pathophysiology of these processes remains to be fully elucidated, imposing hurdles to prevent their development and decelerate their progression. Large animal models are critical for understanding cardio-renal pathophysiology and for the discovery of new therapies. Among them, pig models offer significant translational power to grasp cardio-renal pathophysiology and to test the feasibility and efficacy of new strategies. We recently developed and characterized swine models of CKD, HFpEF, and CKM syndrome that closely recapitulate human disease and allow for the study of the impact of biological variables, such as sex or age, on these conditions. Furthermore, data from these studies revealed key mechanisms implicated in the pathogenesis of CKD, HFpEF, and CKM syndrome and identified potential targets for intervention. This focused mini review highlights the main features of these novel swine models and discusses ongoing and future research aimed at developing novel therapies.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Chronic Kidney Disease I: Introduction

